Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
This guide shows how indices are grouped by country and region, enabling easier cross-market comparisons and analysis.
28,656 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Crypto ownership is now a visible factor in loan underwriting. Banks, insurers and regulators are racing to standardi...
When a major hedge fund trims a stake in a diversified telecom, it sends a message to the market. This article breaks...
Fiserv saw an abrupt share decline after leadership news, even as the company kept its full-year outlook intact. This...
A hypothetical SpaceX IPO could ignite a wave for artificial intelligence (ai) stocks. This article identifies two le...
The cyber threat landscape is expanding, and AI is changing the game. This article explains why the cybersecurity mar...
Across Europe’s boardrooms, English has emerged as the default language, pushing non-native speakers to the margins i...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...
As the Fed weighs its next move, SoFi stock sits at a crossroads. This guide explains how to think through your optio...
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
Palantir Technologies has had a wild ride. If you’re wondering should palantir technologies stock be bought under $14...